A new study suggests that antidepressant use by mothers during the first trimester of pregnancy does not increase the chances of epilepsy and seizures in babies. The research is published in the May 11, 2022, online issue of Neurology®, the medical journal of the American Academy of Neurology.
First-of-its-kind study by Rutgers associates some types of shunts used after epilepsy surgery with brains shifting toward the side of the skull.
Stimulation of certain cerebellar areas could help combat absence seizures.
La brecha de tratamiento de la epilepsia en El Salvador es de 60% a 70%. Junto con la concientización sobre la epilepsia y las necesidades educativas, los recursos son una barrera importante para la atención óptima de las personas con epilepsia.
Announcement of contents of the May 2022 issue of Neurosurgical Focus
Researchers at Tufts University School of Medicine have discovered a previously unknown function performed by a type of cell that comprises nearly half of all cells in the brain. The scientists say this discovery in mice of a new function by cells known as astrocytes opens a whole new direction for neuroscience research that might one day lead to treatments for many disorders ranging from epilepsy to Alzheimer’s to traumatic brain injury.
Since the war began in late February, Ukraine neurologists have been committed to helping citizens with epilepsy, many of whom have lost access to medications and regular care.
He set out to research the effect of polar day-night patterns on seizure frequency and epilepsy. He found something he never expected: a public health crisis in one of the wealthiest countries in the world, relevant to geographically isolated communities and Indigenous peoples.
Epilepsy treatment, and hopefully quality of life for one 18-year-old patient, receives robotic boost at UC San Diego Health.
New study demonstrates that in utero exposure to mother’s antiepileptic or antidepressant medication may affect development of the newborn brain networks.
Scientists at Trinity College Dublin have announced a significant advance in our understanding of epilepsy, as they have identified a potential method of preventing damaging seizure activity.
“We don’t have a lot of the basics that other countries have in terms of health infrastructure, or even our own epilepsy statistics. We are trying to build something from scratch.” - epileptologist Ovidio Solano Cabrera
Mount Sinai Kravis Children’s Hospital will be the first children’s hospital in Manhattan to use a new, state-of-the art seizure monitoring device that facilitates rapid, point-of-care detection and diagnosis of non-convulsive seizure activity in critically ill children to ensure they receive optimal treatment as quickly as possible.
A new study suggests that people with epilepsy associated with head injuries, especially the type not well controlled by medication, are more likely to have other health conditions like depression, post-traumatic stress disorder (PTSD), back pain and headache that may result in them reporting a lower quality of life. The research is published in the April 6, 2022, online issue of Neurology®, the medical journal of the American Academy of Neurology. Other conditions included chronic conditions like high blood pressure, sleep disorders, and behavioral health conditions like anxiety.
Here are some of the latest articles that have been added to the Clinical Trials channel on Newswise.
Cedars-Sinai neurology experts are available to discuss the latest advances in research and clinical care for patients with disorders of the nervous system ahead of the 74th annual meeting of the American Academy of Neurology (AAN), happening April 2-7.
Researchers have found that dysfunction in an important cell subtype in the brain’s neuronal network contribute to chronic symptoms in the neurodevelopmental disorder Dravet syndrome.
Los estudios estiman que al menos un 25% de las personas con epilepsia padece algún trastorno de ansiedad, sin embargo, la ansiedad esta subdiagnosticada e insuficientemente tratada. Comúnmente se presta más atención a la depresión, posiblemente debido al riesgo de suicidio.
A new study from Ann & Robert H. Lurie Children’s Hospital of Chicago published in the journal Epilepsia examined a population of pediatric patients with drug-resistant epilepsy. For these patients, the study found that the patients who received vagus nerve stimulation (VNS), when used with anti-seizure medications (ASM), had lower hospital costs compared to the use of ASM alone. The study found that the patients treated with ASM plus VNS had savings of over $3,000 of epilepsy-related annual costs per year, compared to treatment with ASM only.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right